Sun Pharmaceutical reports 14% surge in Q3 consolidated net profit

31 Jan 2025 Evaluate

Sun Pharmaceutical Industries has reported results for third quarter ended December 31, 2024 (Q3FY25). 

The company has reported 63.74% rise in its net profit at Rs 1181.05 crore for Q3FY25 as compared to Rs 721.31 crore for the same quarter in the previous year. Total income of the company increased by 21.54% at Rs 6260.20 crore for Q3FY25 as compared to Rs 5150.55 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 13.61% rise in its net profit at Rs 2917.54 crore for the quarter ended December 31, 2024, as compared to Rs 2568.03 crore for the same quarter in the previous year. Total income of the company increased by 11.96% at Rs 14141.08 crore for Q3FY25 as compared to Rs 12630.90 crore for the corresponding quarter previous year.

Sun Pharma Inds. Share Price

1581.95 14.75 (0.94%)
05-Mar-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1581.95
Dr. Reddys Lab 1126.55
Cipla 1418.45
Lupin 2009.65
Zydus Lifesciences 887.55
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...